Disney receives final approval for $71Bn 21st Century Fox acquisition
By Akshay Kedari  Date: 2019-03-22

Disney receives final approval for $71Bn 21st Century Fox acquisition
  • The acquisition met success after it received the antitrust regulators’ final approval.
  • The deal covers the entirety of 21st Century Fox movie studio unit, a 30% stake in Hulu as well as the Fox Television Group.

The Walt Disney Company (Disney), a world-renowned American multinational entertainment & mass media conglomerate, has reportedly announced the successful acquisition of New York-based mass-media firm, 21st Century Fox.

Reports cite, the merger went through at approximately 12.02 am (EST), which gave Disney complete control over several 21st Century Fox entities, including the entirety of 21st Century Fox movie studio unit, a 30% stake in Hulu as well as the Fox Television Group.

According to a press release by Walt Disney, among other entities, the Disney acquisition also includes Fox Family & Fox Animation, Fox 2000 Pictures, Fox Searchlight Pictures, National Geographic Partners, Star India, Fox Networks Group International, Endemol Shine Group & Tata Sky.

The Chief Executive Officer of Disney, Bob Iger stated that the acquisition is a historic & extraordinary moment for the company, one that would be generating significant and long-term value for Walt Disney as well as its shareholders. Iger further added that the amalgamation of both parties’ proven talent & extensive creative content would be giving birth to a pre-eminent global-entertainment firm that is well positioned to pilot an incredibly transformative & dynamic era.

Disney’s primary focus would be upon 21st Century Fox’s movie assets, its portfolio of television shows & films as well as its stake in Hulu. Iger had also previously mentioned Disney’s plans to incorporate Fox’s content in the company’s business plans, which also included the possibility of merging Fox franchises like X-Men & Deadpool into the Marvel cinematic universe and facilitating Hulu streaming services internationally.

According to reports, with the completion of the massive acquisition, Walt Disney now has control of approximately 40% of the current market.

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Fibonacci Brands acquires Darwin from Harvest Health & Recreation
Fibonacci Brands acquires Darwin from Harvest Health & Recreation
By Akshay Kedari

Fibonacci Brands has recently announced the acquisition of Darwin from Harvest Health & Recreation (HARV.CN) as its foundation brand. Fibonacci is a leading player in the international cannabis industry. According to James George, founder of Fib...

GVN adds EVIT Center and Chumakov as its new Centers of Excellence
GVN adds EVIT Center and Chumakov as its new Centers of Excellence
By Akshay Kedari

The Global Virus Network (GVN), an international coalition of medical virologists, has recently announced the addition of Australian and Russian researchers. GVN is adding the Center for EVIT (Emerging Viruses, Inflammation & Therapeutics) of th...

Wind Point Partners takes over RTIC to expand business portfolio
Wind Point Partners takes over RTIC to expand business portfolio
By Akshay Kedari

American private equity firm, Wind Point Partners has recently signed an acquisition deal with the one of the biggest direct-to-consumer (D2C) eCommerce providers of drinkware, RTIC. Reportedly, RTIC is Wind Point’s third acquisition of a famil...

Novartis reveals positive data from Phase III ORION trials of inclisiran
Novartis reveals positive data from Phase III ORION trials of inclisiran
By Akshay Kedari

Swiss multinational pharmaceutical firm, Novartis has recently announced results from its Phase III ORION-10 and -11 studies that focus on assessing the individual responses of patients on lowering low-density lipoprotein cholesterol (LDL-C) with inc...

Medtronic to acquire Companion Medical to expand diabetes business
Medtronic to acquire Companion Medical to expand diabetes business
By Akshay Kedari

Medtronic plc, the global leader in medical technologies, has reportedly announced that it is planning to acquire insulin pen manufacturer Companion Medical. The acquisition gives Medtronic access to Companion Medical’s ‘InPen’, wh...